Short Steroid Courses Linked to Increased Pneumonia and Heart Failure Risk in Type 2 Diabetes Patients
Source Summary
Short, high-dose courses of oral corticosteroids used to treat allergy and asthma flare-ups are linked to higher risks of pneumonia and heart failure in adults with type 2 diabetes. These medications, while effective at rapidly reducing inflammation, can disrupt the body's glucose regulation system, causing blood sugar levels to rise dangerously.
Why it matters
The finding highlights a significant safety concern for the millions of type 2 diabetes patients who may require short-term steroid treatment for common respiratory conditions, potentially requiring adjusted clinical management strategies.
